FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the dosage form of azathioprine, which is characterized by being made in the form of a solid gelatin capsule, with the following content of components in mg: azathioprine 50.00, lactose monohydrate 108.76, corn starch 18.00, calcium stearate 1.80, crospovidone 0.90, and gelatin 0.54.
EFFECT: proposed dosage form has no solid tablet forms disadvantages.
1 cl, 1 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITIONS CONTAINING FENOSANIC ACID | 2019 |
|
RU2731536C1 |
| PHARMACEUTICAL ANTIFUNGAL COMPOSITION BASED ON A CHLOROPHENYLBUTANEDIONE DERIVATIVE AND A METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2707286C1 |
| AFOBASOL-BASE PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2289403C2 |
| PHARMACEUTICAL COMPOSITIONS FOR TREATING CEREBROVASCULAR DISORDERS AND METHODS FOR PREPARING THEM | 2012 |
|
RU2559776C2 |
| SOLID DOSAGE FORM OF PROCARBAZINE OF IMMEDIATE RELEASE AND PREPARATION METHOD THEREOF | 2014 |
|
RU2586290C1 |
| ORAL PHARMACEUTICAL COMPOSITION OF DIURETICS AND ACE INHIBITOR IN MICRONIZED FORM, DRUG AND ITS APPLICATION | 2012 |
|
RU2618471C2 |
| METHOD FOR MAKING SOLID ORAL PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2379036C2 |
| METHOD FOR PREPARING SOLID, ORAL PHARMACEUTICAL FORMULATION | 2009 |
|
RU2493850C2 |
| PHARMACEUTICAL ANTI-DIABETIC COMPOSITION BASED ON SUBSTITUTED THIOPHENE CARBOXYLATE AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2688235C1 |
| CHEMICALLY STABLE AND THERMOSTABLE READY FORMS OF NORASTEMIZOL | 1998 |
|
RU2214245C2 |
